---

国際学会

▲TOPへ戻る 14th International Myeloma Workshop (2013.4.3-7, Kyoto International Conference Center, Kyoto, Japan, Shimizu K)
Sata H, Shibayama H, Maeda I, Fukushima K, Fujita J, Ezoe S, Tadokoro S, Maeda T, Mizuki M, Oritani K, Kosugi S, Nakagawa M, Ueda S, Tokumine Y, Iida M, Azenishi Y, Mitsui H, Kanakura Y
(発表日4.4)(Poster) Detection of patient-specific MRD with quantitative RT-PCR in the patients with multiple myeloma

The 18th Congress of European Hematology Association (2013.6.13-16, Stockholm International Fairs & Congress Center, Stockholm, Sweden, Sierra J)
Ichii M, Oritani K, Yokota T, Ishibashi T, Sudo T, Fujita N, Kincade PW, Kanakura Y
(発表日6.15)(Poster) Analysis of human endosteal HSC niche; a novel CD34high ESAMhigh subset is adjacent to trabecular areas of human bone marrow

Michel M, Wasser J, Godeau B, Aledort L, Cooper N, Tomiyama Y, Khellaf M, Wang X, Woodard P
(発表日6.14)( Poster) Efficacy and Safety of Romiplostim in Patients ≥65 Years With Immune Thrombocytopenia

The 24th Congress of the International Society on Thrombosis and Haemostasis (2013.6.29-7.4, Amsterdam RAI, Amsterdam, Netherland, Rosendaal F)
Tomiyama Y, Kiyomizu K, Kashiwagi H
(発表日6.29)(SSC meeting, Oral) Autoantigenic epitopes on GPIIb-IIIa in ITP

Kashiwagi H, Kunishima S, Kiyomizu K, Amano Y, Shimada H, Morishita M, Kanakura Y, Tomiyama Y
(発表日7.4) Demonstration of novel gain-of- function mutations of αIIbβ3:association with macro- thrombocytopenia and glanzmann thrombasthenia-like phenotype

The American Society of Hematology 55th Annual Meeting (2013.12.7-10, Ernest N. Morial Convention Center, New Orleans, LA, USA, Abkowitz JL)
Nishimura J, Yamamoto M, Hayashi S, Ohyashiki K, Ando K, Noji H, Kitamura K, Eto T, Takahashi T, Masuko M, Matsumoto T, Wano Y, Shichishima T, Shibayama H, Hase M, Lan L, Johnson K, Tamburini P, Inazawa J, Kinoshita T, Kanakura Y
(発表日12.9)(Poster) A Rare Genetic Polymorphism In C5 Confers Poor Response To The Anti-C5 Monoclonal Antibody Eculizumab In 11 Japanese Patients With PNH

Yokota T, Oritani K, Sudo T, Ishibashi T, Doi Y, Habuchi Y, Ichii M, Okuzaki D, Tomizuka K, Yamawaki K, Kakitani M, Shimono A, Morii E, Kincade PW, Kanakura Y
(発表日12.8)(Poster) SFRP5 inhibits early stages of B-cell differentiation and modulates estrogen-related changes in the immune system

Matsui K, Ezoe S, Yokota T, Ishibashi T, Oritani K, Kanakura Y
(発表日12.7)(Poster) Iron overload effects on immune system through the cytokine secretion by macrophage

Ishibashi T, Yokota T, Ichii M, Satoh Y, Sudo T, Doi Y, Fujita N, Nagate Y, Hamanaka Y, Matsui K, Tanimura A, Saitoh N, Ezoe S, Shibayama H, Kincade PW, Oritani1 K, Kanakura Y
(発表日12.8)(Poster) Endothelial Cell-Selective Adhesion Molecule Marks Human Hematopoietic Stem Cells Regardless Of The HSC Sources

Miyakawa Y, Katsutani S, Yano T, Nomura S, Nishiwaki K, Tomiyama Y, Higashihara M, Shirasugi Y,Nishikawa M, Ozaki K, Kikuchi K, Abe T, Sato Y, Kanakura Y, Fujimura K, Ikeda Y, Okamoto S
(発表日12.9)(Poster) Rituximab as second-line treatment for chronic immune thrombocytopenia: investigator-initiated clinical trial in Japan

Tanaka H, Kosugi S, Kida T, Ohta K, Yamamura R, Shibayama H, Kohara T, Kaneko H, Fuchida S, Kobayashi M, Miyamoto K, Shindo M, Kuroda J, Uoshima N, Matsumura Y, Yoshii Y, Kamitsuji Y, Boku S, Ishii K, Matsuda M, Takahashi T, Hamada T, Adachi Y, Nakatani E, Nomura S, Taniwaki M, Takaori A, Shimazaki C, Tsudo M, Hino M, Matsumura I, Kanakura Y
(発表日12.8)(Poster) Retrospective Analysis Of The Recent Treatment Strategies For The Patients With Myeloma-Related Diseases Registered In Kansai Myeloma Forum

Obara N, Chiba S, Hosokawa K, Sugimori C, Yamamoto M, Noji H, Yonemura Y, Nakamura Y, Ando K, Kawaguchi T, Shichishima T, Ninomiya H, Nishimura J, Kanakura Y, Nakao S
(発表日12.7)(Poster) Baseline assessment of GPI-anchored protein deficient blood cells in patients with bone marrow failure (The OPTIMA study)

Usuki K, Urabe A, Kawaguchi T, Miyasaka N, Miura O, Morishita E, Arima N, Morita Y, Nishiwaki K, Ninomiya H, Gotoh A, Imashuku S, Shichishima T, Nishimura J, Kanakura Y
(発表日12.8)(Poster) Management of pregnancy in paroxysmal nocturnal hemoglobinuria (PNH): A report of 10 cases from the working group on pregnancy of the Japan PNH study group

Hamada Y, Tamura H, Ishibashi M, Okuyama N, Kondo A, Moriya K, Ogata K, Kakumoto K, Miyazaki Y, Matsuda A, Tohyama K, Ueda Y, Kurokawa M, Shibayama H, Emi N, Mitani K, Naoe T, Sugiyama H, Inokuchi K
(発表日12.8)(Poster) CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients

Kobayashi S, Ueda Y, Kurokawa M, Ogata K, Shibayama H, Emi N, Usuki K, Ohyashiki K, Ozawa K, Miyazaki Y, Matsuda A, Tohyama K, Mitani K, Naoe T, Sugiyama H
(発表日12.8)(Poster) WT-1 Expression Level In BM Is The Great Prognostic Marker In Three Of Classification IPSS, WPSS, and Latest Revised IPSS(IPSS-R)

Miyamura K, Miyamoto T, Kurokawa M, Tanimoto M, Yamamoto K, Taniwaki M, Kimura S, Ohyashiki K, Kawaguchi T, Matsumura I, Hata T, Tsurumi H, Saito S, Hino M, Tadokoro S, Meguro K, Hyodo H, Yamamoto M, Kubo K, Tsukada J, Kondo M, Amagasaki T, Kawahara E, Yanada M
(発表日12.8)(Poster) Nilotinib Following Molecular Suboptimal Response (SoR) To Imatinib In Japanese Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): 12 Month Follow-Up From The SENSOR Study